Covered recipient · General Payments record
RACHANA N SUS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$998.61
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $438.53 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $152.85 | 3 |
| Novo Nordisk AS | $97.53 | 5 |
| Amgen Inc. | $75.26 | 3 |
| SANOFI-AVENTIS U.S. LLC | $43.97 | 2 |
| DEXCOM, INC. | $28.33 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $24.22 | 1 |
| Corcept Therapeutics | $16.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $29.10 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116163048 | CMS |
| Amgen Inc. | $17.47 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116163061 | CMS |
| Amgen Inc. | $28.69 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116163054 | CMS |
| Corcept Therapeutics | $16.37 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117778482 | CMS |
| Dexcom, Inc. | $28.33 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153328861 | CMS |
| Lilly USA, LLC | $18.49 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135298114 | CMS |
| Lilly USA, LLC | $121.81 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135329251 | CMS |
| Lilly USA, LLC | $12.55 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135323350 | CMS |
| Novo Nordisk Inc | $18.74 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097742931 | CMS |
| Novo Nordisk Inc | $22.64 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096765234 | CMS |
| Novo Nordisk Inc | $21.55 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096890346 | CMS |
| Novo Nordisk Inc | $16.30 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096682108 | CMS |
| Novo Nordisk Inc | $18.30 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097217938 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $24.22 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139166743 | CMS |
| SANOFI-AVENTIS U.S. LLC | $22.79 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139663664 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.18 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139663740 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.